SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst a government shutdown, sparking heated debates about healthcare for undocumented immigrants and the release of the Epstein files. The community is divided, with opinions clashing over political affiliations, economic policies, and the role of government. Discussions range from concerns about the shutdown's impact to accusations of political corruption and influence.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the community discusses its potential as a safe haven amid government shutdown concerns and anticipation for a historically strong October. Bullish sentiment is fueled by the expectation of institutional adoption and potential price surges, while some traders remain cautious, watching key resistance levels and potential market corrections.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending amidst concerns about a potential government shutdown and its possible impact on markets. While some traders anticipate a market dip due to the shutdown, others point to historical data suggesting previous shutdowns led to market gains, creating mixed community sentiment. Discussions also revolve around inflation, potential economic impacts, and political reactions to the shutdown.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending following a surprise revenue increase and earnings beat, fueling investor optimism about the company's turnaround efforts despite ongoing concerns about tariffs and weakness in the Chinese market. Bullish sentiment is growing, with analysts upgrading price targets and the community anticipating a potential short squeeze. Discussions also focus on the evolving competitive landscape and Nike's strategic collaborations, such as the partnership with SKIMS.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart is trending amid a recent pullback, leading to divided opinions on potential bottom-fishing versus further downside. Community members are actively discussing short squeeze opportunities, potential support levels, and the impact of broader market factors like interest rates and a possible government shutdown. Some traders point to a BTIG analyst report raising concerns about delinquencies as a catalyst for the stock's recent struggles.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

RDDT is trending as the stock experiences volatility, with community members debating whether to buy the dip or anticipate further decline. Discussions include potential support levels and upcoming events, while some traders point to positive analyst ratings and long-term growth potential despite near-term concerns. A potential hearing in Congress is also on investors' radars.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

BYTE.X is trending as the community rallies behind it as a potential mascot for xAI and Grok, with some speculating about Elon Musk's interest. Community members highlight the strong community, zero taxes, and burned liquidity as reasons to be bullish. There is also discussion around the existence of scam versions of the token.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst is trending as investors digest the implications of the completed sale of its European business, with community discussions focused on whether this move signals a potential acquisition of the company or a shift in strategic direction. Some express concern about management decisions and the stock's performance relative to its peers, while others remain optimistic about the long-term potential and upcoming data readouts. Chatter also revolves around the impact of potential competition from new drugs in the HAE market.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DKNG is trending downwards as the community discusses potential competition from prediction markets like Kalshi and Robinhood, which some believe could draw users away from traditional sports betting. Investors are also concerned about the company's leadership and its ability to innovate in the face of increasing competition. Some senators are expressing concerns about the legality of event contracts used for sports betting.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a controversy sparked by an FDA official's LinkedIn post questioning the safety and efficacy of Aurinia's drug, which led to a significant stock drop. The community is actively discussing potential motives behind the post, including a possible personal vendetta, and calling for accountability and investigations into market manipulation. Amidst the turmoil, some investors see this as a buying opportunity, while others express concerns about trust in leadership and the FDA.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?

ETFs to Capitalize on the Novo Nordisk-Septerna Deal

Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk

Danish drug maker Novo Nordisk (NVO) on Tuesday announced an exclusive global collaboration and license agreement with U.S.-based Septerna, Inc. (SEPN) to discover, develop, and commercialise oral small-molecule medicines for obesity, type 2 diabetes, and other cardiometabolic diseases.The company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916006">said</a> the deal could be worth up to $2.2 billion. This includes more than $200 million in upfront and near-term milestone payments to Septerna and additional research, development, and commercial milestone payments.The California-based company is also eligible to receive tiered royalties on global net sales of marketed products.Novo Nordisk will cover all research and development expenses for partnered programs under the collaboration.The agreement is expected to close in the second quarter of 2025.The companies will initially commence four development programmes for potential small-molecule therapies directed at select G-protein-coupled receptor (GPCR) targets. GPCRs are a large and diverse family of cell membrane proteins involved in cellular communication.Septerna CEO Jeffrey Finer said that the collaboration provides an opportunity to create multiple oral medicines and provides the company with the operational flexibility and resources to advance its portfolio of other GPCR-targeted programmes.On Stocktwits, retail sentiment around Novo Nordisk fell from ‘bullish’ to ‘bearish’ territory over the past 24 hours while message volume dropped from ‘extremely high’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:629/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_14_at_8_28_57_AM_png_13db4d5cfd.webp" alt="Screenshot 2025-05-14 at 8.28.57 AM.png" width="629" height="64"><figcaption>NVO's Sentiment Meter and Message Volume as of 8:30 a.m. ET on May 14, 2025 | Source: Stocktwits</figcaption></figure> Meanwhile, retail sentiment on Septerna jumped from ‘bearish’ to ‘extremely bullish’ territory while message volume jumped from ‘normal’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:628/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_14_at_8_31_56_AM_png_a149898af9.webp" alt="Screenshot 2025-05-14 at 8.31.56 AM.png" width="628" height="62"><figcaption>SEPN's Sentiment Meter and Message Volume as of 8:35 a.m. ET on May 14, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user expressed concerns about the new agreement, opining that Septerna’s pipeline is in the “early stage.”<stembedurl>https://stocktwits.com/NEVER_SAY_TRANSITORY/message/614571231</stembedurl>However, another investor expressed optimism on the stock if it breaks the $12.40 mark.<stembedurl>https://stocktwits.com/Trad3Slinger/message/614572114</stembedurl><a href="https://stocktwits.com/symbol/SEPN">SEPN stock</a> is up by about 70% in premarket trading on Wednesday.The stock is down by 68% this year and nearly 69% over the past 12 months.<a href="https://stocktwits.com/symbol/NVO">NVO stock</a>, meanwhile, is trading nearly 3% higher in pre-market.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nvidia-backed-databricks-acquires-database-startup-neon/chiqpslRbNL">Nvidia, Microsoft-Backed Databricks Bets Big On AI Agents With $1B Neon Takeover: Retail Turns Extremely Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Novo Nordisk logo is displayed on a smartphone with stock market percentages in the background. (Photo Illustration by Omar Marques/SOPA Images/LightRocket via Getty Images)

Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled

Septerna CEO Jeffrey Finer said that the collaboration allows the company to create multiple oral medicines and provides the operational flexibility and resources to advance its portfolio of other GPCR-targeted programmes.

Equity

Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones

Analysts initiated coverage on Septerna, Inc. with Overweight ratings and price targets of $50 and $38. SEPN's innovative platform and potential pipeline make it a promising biopharma player.
read...

Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.

Septerna Inc.

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$18.81
Prev Close	$18.15
Open	$18.04
Dividend Yield	0.00%
50-Day Moving Average	$13.52
Beta	1.43
Avg. Volume	230,385.29
PE Ratio	-8.74

52-Week High	$28.99
52-Week Low	$4.17
Market Capitalization	$838.65M
EPS (Annual)	-$1.62
Price to Book	2.22
Revenue Per Employee	$14,333.33
Enterprise Value/EBITDA	N/A

SEPN
Septerna Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SEPN News

SEPN Septerna Inc.